Minhao Fan

692 total citations
11 papers, 531 citations indexed

About

Minhao Fan is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Minhao Fan has authored 11 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Minhao Fan's work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (3 papers). Minhao Fan is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (3 papers). Minhao Fan collaborates with scholars based in China, United States and Poland. Minhao Fan's co-authors include Xichun Hu, Biyun Wang, Jian Zhang, Qunling Zhang, Wei Huang, Jifeng Feng, Xiaojia Wang, Binghe Xu, Si Sun and Joseph Ragaz and has published in prestigious journals such as International Journal of Cancer, Journal of Hematology & Oncology and Oncotarget.

In The Last Decade

Minhao Fan

10 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minhao Fan China 6 305 268 175 134 55 11 531
Shinji Nakamichi Japan 13 281 0.9× 268 1.0× 238 1.4× 88 0.7× 82 1.5× 51 566
Riccardo Ricotta Italy 13 307 1.0× 192 0.7× 165 0.9× 141 1.1× 33 0.6× 37 511
Andrea Ravelli Italy 10 288 0.9× 251 0.9× 200 1.1× 106 0.8× 70 1.3× 15 543
Hielke J. Meulenbeld Netherlands 11 283 0.9× 316 1.2× 149 0.9× 176 1.3× 89 1.6× 17 577
Tzu‐Hsiu Tsai Taiwan 13 372 1.2× 471 1.8× 183 1.0× 178 1.3× 48 0.9× 17 611
Ruixuan Geng China 12 254 0.8× 196 0.7× 234 1.3× 148 1.1× 54 1.0× 29 556
Tianqing Chu China 12 317 1.0× 277 1.0× 227 1.3× 163 1.2× 46 0.8× 46 606
Johann Raats South Africa 9 367 1.2× 280 1.0× 188 1.1× 83 0.6× 101 1.8× 15 569
Daniele Lavacchi Italy 12 303 1.0× 184 0.7× 124 0.7× 85 0.6× 82 1.5× 46 476
Qiong Zhao China 14 299 1.0× 196 0.7× 145 0.8× 82 0.6× 70 1.3× 28 503

Countries citing papers authored by Minhao Fan

Since Specialization
Citations

This map shows the geographic impact of Minhao Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhao Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhao Fan more than expected).

Fields of papers citing papers by Minhao Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minhao Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhao Fan. The network helps show where Minhao Fan may publish in the future.

Co-authorship network of co-authors of Minhao Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Minhao Fan. A scholar is included among the top collaborators of Minhao Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minhao Fan. Minhao Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Zhang, Heng, Minhao Fan, Yang Hu, et al.. (2025). Prognostic Assessment and Analysis of Underlying Biological Mechanisms of Prostate Cancer Based on Estrogen-Related Genes. Hormone and Metabolic Research. 57(4). 273–285. 1 indexed citations
3.
Cheng, Ying, Yong He, Wěi Li, et al.. (2021). Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study. Targeted Oncology. 16(2). 165–176. 90 indexed citations
4.
Zhou, Chao, Ying Cheng, Yong He, et al.. (2018). P1.01-112 Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC. Journal of Thoracic Oncology. 13(10). S507–S508. 3 indexed citations
5.
Hu, Xichun, Wei Huang, & Minhao Fan. (2017). Emerging therapies for breast cancer. Journal of Hematology & Oncology. 10(1). 98–98. 54 indexed citations
6.
Zhang, Jian, Minhao Fan, Jie Xie, et al.. (2015). Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy. Oncotarget. 6(40). 43135–43143. 32 indexed citations
7.
Li, Ting, Qunling Zhang, Jian Zhang, et al.. (2014). Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer. 14(1). 96–96. 66 indexed citations
8.
Hu, Xichun, Jian Zhang, Binghe Xu, et al.. (2014). Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer. International Journal of Cancer. 135(8). 1961–1969. 218 indexed citations
9.
Li, Ting, Minhao Fan, Ruohong Shui, et al.. (2014). Pathology-Confirmed Granuloma Mimicking Liver Metastasis of Breast Cancer. The International Journal of Biological Markers. 29(1). e93–e97. 1 indexed citations
10.
Fan, Minhao, Jian Zhang, Zhonghua Wang, et al.. (2013). Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy. Breast Cancer Research and Treatment. 143(1). 141–151. 63 indexed citations
11.
Hu, Xichun, Jian Zhang, Binghe Xu, et al.. (2013). BP40 MULTICENTER PHASE II STUDY OF APATINIB, A NOVEL INHIBITOR OF VEGFR, IN HEAVILY PRETREATED PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER. The Breast. 22. S33–S33. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026